Negative regulation by protein tyrosine phosphatase of IFN-γ-dependent expression of inducible nitric oxide synthase

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6776-6783

  Díaz Guerra, María J M ^a   Castrillo, Antonio ^a   Martín Sanz, Paloma ^a   Boscá, Lisardo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; DNA FLANKING REGION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; DRUG SYNERGISM; I-KAPPA B PROTEINS; INTERFERON TYPE II; MACROPHAGES, PERITONEAL; MALE; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION; TYROSINE; VANADATES;

EID: 0033153484     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. van Rooijen, N., and A. Sanders. 1997. Elimination, blocking, and activation of macrophages: three of a kind? J. Leukocyte Biol. 62:702.
2. Celada, A., and C. Nathan. 1994. Macrophage activation revisited. Immunol. Today 15:100.
3. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
4. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of IFN-γ and its receptor. Annu. Rev. Immunol. 11:571.
5. Berlett, B. S., and E. R. Stadtman. 1997. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272:20313.
6. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
7. Collins, T., M. A. Read, A. S. Neish, M. Z. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules, NF-κB and cytokine-inducible enhancers. FASEB J. 9:899.
8. Decker, T., P. Kovarik, and A. Meinke. 1997. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cylokine Res. 17:121.
9. Haque, S. J., V. Flati, A. Deb, and B. R. Williams. 1995. Roles of protein-tyrosine phosphatases in Stat 1 α-mediated cell signaling. J. Biol. Chem. 270:25709.
10. Ruff, S. J., K. Chen, and S. Cohen. 1997. Peroxovanadate induces tyrosine phosphorylation of multiple signaling proteins in mouse liver and kidney. J. Biol. Chem. 272:1263.
11. Haque, S. J., Q. Wu, W. Kammer, K. Friedrich, J. M. Smith, I. M. Kerr, G. R. Stark, and B. R. Williams. 1997. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. Proc. Natl. Acad. Sci. USA 94:8563.
12. Nathan, C., and Q.-w. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915.
13. Nathan, C., and Q.-w. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725.
14. MacMicking, J., Q.-w. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323.
15. Gao, J., D. C. Morrison, T. J. Parmely, S. W. Russell, and W. J. Murphy. 1997. An IFN-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to IFN-γ and lipopolysaccharide. J. Biol. Chem. 272:1226.
16. Martin, E., C. Nathan, and Q.-w. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977.
17. Lowenstein, C. J., E. W. Alley, P. Raval, A.M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by IFN-γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:9730.
18. Xie, Q.-w., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1779.
19. Goldring, C. E., S. Reveneau, M. Algarte, and J. F. Jeannin. 1996. In vivo foot-printing of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6. Nucleic Acids Res. 24:1682.
20. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
21. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529.
22. Velasco, M., M. J. M. Diaz-Guerra, P. Maitin-Sanz, A. Alvarez, and L. Boscá. 1997. Rapid up-regulation of IκBβ and abrogation of NF-κB activity in peritoneal macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 272:23025.
23. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997. IκB kinase-K: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866.
24. Mercurio, F., H. Zhu, B.W. Murray, A. Shevchenko, B. L. Bennett, I. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine activated IκB kinases essential for NF-κB activation. Science 278:860.
25. Imbert, V., R. A. Rupee, A. Livolsi, H. L. Pahl, E. B. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, and P. A. Baeuerle. 1996. Tyrosine phosphorylation of IκB-α activates NFκB without proteolytic degradation of IκB-α. Cell 86:787.
26. Koong, A. C., E. Y. Chen, N. F. Mivechi, N. C. Denko, P. Stambrook, and A. J. Giaccia. 1994. Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res. 54:5273.
27. Diaz-Guerra, M. J. M., M. Velasco, P. Maitin-Sanz, and L. Bosca. 1996. Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes: requirement of NF-κB activation after stimulation with bacterial cell wall products and phorbol esters J. Biol. Chem. 271:30114.
28. Spink, J., J. Cohen, and T. J. Evans. 1995. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase: activation by nuclear factor-κB. J. Biol. Chem. 270:29541.
29. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts" prepared from a small number of cells. Nucleic Acids Res. 17:6419.
30. Sadowski, H. B., K. Shuai, J. E. Damell, Jr., and M. Z. Gilman. 1993. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739.
31. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, T. W. Mak, T. Taniguchi, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612.
32. Ralph, P., and I. Nakoinz. 1977. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enrichment by PPD and LPS. J. Immunol. 119:950.
33. Raschke, W. C., S. Baird, P. Ralph, and I. Nakoinz. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261.
34. Lorsbach, R. B., W. J. Murphy, C. J. Lowenstein, S. H. Snyder, and S. W. Russell. 1993. Expression of the nitric oxide synthase gene in mouse mac-rophages activated for tumor cell killing: molecular basis for the synergy between interferon-γ and lipopolysaccharide. J. Biol. Chem. 268:1908.
35. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79.
36. Lopez-Collazo, E., S. Hortelano, A. Rojas, and L. Bosca. 1998. Triggering of peritoneal macrophages with IFN-α/β attenuates the expression of inducible nitric oxide synthase through a decrease in NF-κB activation. J. Immunol. 160:2889.
37. Griscavage, J. M., S. Wilk, and L. J. Ignarro. 1996. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB. Proc. Natl. Acad. Sci. USA 93:3308.
38. Singh, S., B. G. Damay, and B. B. Aggarwal. 1996. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation. J. Biol. Chem. 271:31049.
39. Weiss, A., and J. Schlessinger. 1998. Switching signals on or off by receptor dimerization. Cell 94:277.
40. English, B. K., S. L. Orlicek, Z. Mei, and E. A. Meals. 1997. Bacterial LPS and IFN-γ trigger the tyrosine phosphorylation of vav in macrophages: evidence for involvement of the hck tyrosine kinase. J. Leukocyte Biol. 62:859.
41. Noble, P.W., C. M. McKee, M. Cowman, and H. S. Shin. 1996. Hyaluronan fragments activate an NF-κB/I-κBα autoregulatory loop in murine macrophages. J. Exf. Med. 183:2373.
42. Sonoda, Y., T. Kasahara, Y. Yamaguchi, K. Kuno, K. Matsushima, and N. Mukaida. 1997. Stimulation of interleukin-8 production by okadaic acid and vanadate in a human promyelocyte cell line, an HL-60 subline: possible role of mitogen-activated protein kinase on the okadaic acid-induced NF-κB activation. J. Bid. Chem. 272:15366.
43. Thompson, J. E., R. J Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573.
44. Ishii, T., T. Yanagawa, T. Kawane, K. Yuki, J. Seita, H. Yoshida, and S. Bannai. 1996. Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p561ck-associated protein in response to oxidative stress. Biochem. Biophys. Res. Common. 226:456.
45. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299.
46. Ruetten, H., and C. Thiemermann. 1997. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Br. J. Pharmacol. 122:59.
47. Meng, F., and C. A. Lowell. 1997. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. Med. 185:1661.
48. Melillo, G., L. S. Taylor, A. Brooks, G. W. Cox, and L. Varesio. 1996. Regulation of inducible nitric oxide synthase expression in IFN-γ-treated murine macrophages cultured under hypoxic conditions. J. Immunol. 157:2638.
49. Melillo, G., L. S. Taylor, A. Brooks, T. Musso, G. W. Cox, and L. Varesio. 1997. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272:12236.
50. Druker, B. J., M. Neumann, K. Okuda, B. R. Franza, Jr., and J. D. Griffin. 1994. rel Is rapidly tyrosine-phosphorylated following granulocyte-colony stimulating factor treatment of human neutrophils. J. Biol. Chem. 269:5387.
51. Sharf, R., D. Meraro, A. Azriel, A.M. Thoraton, K. Ozato, E.F. Petricoin, A. C. Lamer, F. Schaper, H. Hauser, and B. Z. Levi. 1997. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. Biol. Chem. 272:9785.
52. Cheschire, J. L., and A. S. Baldwin, Jr. 1997. Synergistic activation of NF-κB by tumor necrosis factor a and y interferon via enhanced IκBα degradation and de novo IκBβ degradation. Mol. Cell. Biol. 17:6746.